|Dr. James Timourian||Chairman, CEO, Pres & Sec.||18k||N/A||N/A|
|Mr. Alan C. Savage||CFO & Director||N/A||N/A||1943|
|Dr. Amin Omar||Chief Operating Officer||121.97k||N/A||N/A|
|Dr. Merle Olson||Scientific Consultant||N/A||N/A||N/A|
Innovotech Inc. provides services and solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada and internationally. The company's products include InnovoSIL, the antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and Agress/AgreGuard, an environmentally friendly seed treatments and plant sprays to protect crops against both bacterial and fungal infections. Its products also include MBEC Assay's biofilm inoculator comprising plastic lids with 96 pegs to simulate the surface conditions on which microorganisms attach and grow. The company's services cover implant medical devices, bacteriophage and cytotoxicity testing, and in vitro antimicrobial testing, as well as antibiotic, antimicrobial, and biocide resistance. It serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food safety, transportation, and healthcare. The company is headquartered in Edmonton, Canada.
Innovotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.